Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1969 Nov;5(5):443–459.

Epstein–Barr virus-associated antibody patterns in carcinoma of the post-nasal space

A de Schryver, S Friberg, G Klein, W Henle, G Henle, G de-Thé, P Clifford, H C Ho
PMCID: PMC1579142  PMID: 4902604

Abstract

Sera from African patients with tumours of the post-nasal space, Hong Kong Chinese patients with carcinomas of the post-nasal space and from Indian donors with buccal, oro- and hypopharyngeal carcinomas, as well as African control sera from healthy persons and individuals with various non-neoplastic and neoplastic diseases were tested for anti-Epstein–Barr virus titres and for antibodies capable of blocking the direct membrane immunofluorescence reaction obtained between Epstein-Barr virus carrying lymphoblastoid cell lines and two different fluorescein conjugated reference sera; one from a patient with Burkitt lymphoma (F-Mutua conjugate) and the other from a patient with carcinoma of the post-nasal space (F-Kipkoech conjugate). Ninety per cent or more of the African and Chinese patients with carcinoma of the post-nasal space gave at least one high test, and 60% were high in all three assays. In contrast, African patients with post-nasal space tumours other than carcinomas, African controls and Indian buccal, oro- and hypopharyngeal carcinomas gave high reactions in all three assays in less than 20%.

Full text

PDF
443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clifford P. Carcinoma of the nasopharynx in Kenya. East Afr Med J. 1965 Jul;42(7):373–396. [PubMed] [Google Scholar]
  2. Diehl V., Henle G., Henle W., Kohn G. Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol. 1968 Jul;2(7):663–669. doi: 10.1128/jvi.2.7.663-669.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goldstein G., Klein G., Pearson G., Clifford P. Direct membrane immunofluorescence reaction of Burkitt's lymphoma cells in culture. Cancer Res. 1969 Apr;29(4):749–752. [PubMed] [Google Scholar]
  4. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hinuma Y., Konn M., Yamaguchi J., Wudarski D. J., Blakeslee J. R., Jr, Grace J. T., Jr Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol. 1967 Oct;1(5):1045–1051. doi: 10.1128/jvi.1.5.1045-1051.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Klein G., Clifford P., Klein E., Smith R. T., Minowada J., Kourilsky F. M., Burchenal J. H. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J Natl Cancer Inst. 1967 Nov;39(5):1027–1044. [PubMed] [Google Scholar]
  8. Klein G., Pearson G., Henle G., Henle W., Diehl V., Niederman J. C. Relation between Epstein-- Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt's lymphoma and infectious mononucleosis. J Exp Med. 1968 Nov 1;128(5):1021–1030. doi: 10.1084/jem.128.5.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Klein G., Pearson G., Henle G., Henle W., Goldstein G., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. J Exp Med. 1969 Apr 1;129(4):697–705. doi: 10.1084/jem.129.4.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Levy J. A., Henle G. Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells. J Bacteriol. 1966 Jul;92(1):275–276. doi: 10.1128/jb.92.1.275-276.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Niederman J. C., McCollum R. W., Henle G., Henle W. Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA. 1968 Jan 15;203(3):205–209. doi: 10.1001/jama.203.3.205. [DOI] [PubMed] [Google Scholar]
  12. Oettgen H. F., Aoki T., Geering G., Boyse E. A., Old L. J. Definition of an antigenic system associated with Burkitt's lymphoma. Cancer Res. 1967 Dec;27(12):2532–2534. [PubMed] [Google Scholar]
  13. Old L. J., Boyse E. A., Geering G., Oettgen H. F. Serologic approaches to the study of cancer in animals and in man. Cancer Res. 1968 Jul;28(7):1288–1299. [PubMed] [Google Scholar]
  14. Old L. J., Boyse E. A., Oettgen H. F., Harven E. D., Geering G., Williamson B., Clifford P. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699–1704. doi: 10.1073/pnas.56.6.1699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pearson G., Klein G., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence. J Exp Med. 1969 Apr 1;129(4):707–718. doi: 10.1084/jem.129.4.707. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES